a public good project by the
Synthesis
Company
of California

© 2026

Fredrik Scherstén | doi.page

0 works0 citations0 h-index

Fredrik Scherstén

Lund University(SE)Skåne University Hospital(SE)

Publications by Year

Research Areas

Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases, Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes

Most-Cited Works

→ Bivalirudin versus Heparin Monotherapy in Myocardial Infarction(2017)288 cited
→ Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden(2009)235 cited
→ Stent Thrombosis in Sweden(2009)127 cited
→ Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score(2012)85 cited
→ Delay From First Medical Contact to Primary PCI and All‐Cause Mortality: A Nationwide Study of Patients With ST‐Elevation Myocardial Infarction(2014)78 cited
→ Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention(2011)75 cited

→ Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)(2009)

67 cited

→ Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome(2014)58 cited

→ Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic(2020)55 cited

→ Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock(2018)47 cited